Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 986,315 | 953,928 | 921,000 | 835,083 | 865,776 |
| Cost of Goods | 407,501 | 385,477 | 365,000 | 346,412 | 359,340 |
| Gross Profit | 578,814 | 568,451 | 556,000 | 488,671 | 506,436 |
| Operating Expenses | 358,419 | 360,071 | 341,000 | 314,344 | 299,572 |
| Operating Income | 220,896 | 208,857 | 215,000 | 175,738 | 207,204 |
| Interest Expense | 9,652 | 9,008 | 7,000 | 7,023 | 4,728 |
| Other Income | 9,912 | 28,239 | 18,000 | 18,893 | 16,608 |
| Pre-tax Income | 221,156 | 228,087 | 226,000 | 187,608 | 219,084 |
| Income Tax | 55,507 | 68,449 | 59,000 | 34,217 | 53,616 |
| Net Income Continuous | 165,648 | 159,639 | 167,000 | 153,390 | 165,468 |
| Minority Interests | -1,121 | 10,258 | N/A | N/A | N/A |
| Net Income | $166,769 | $149,381 | $167,000 | $153,390 | $165,468 |
| EPS Basic Total Ops | 0.20 | 0.04 | 0.20 | 0.19 | 0.20 |
| EPS Basic Continuous Ops | 0.20 | 0.04 | 0.20 | 0.19 | 0.20 |
| EPS Diluted Total Ops | 0.20 | 0.04 | 0.20 | 0.19 | 0.20 |
| EPS Diluted Continuous Ops | 0.20 | 0.04 | 0.20 | 0.19 | 0.20 |
| EPS Diluted Before Non-Recurring Items | 0.20 | 0.04 | 0.20 | N/A | N/A |
| EBITDA(a) | $273,896 | $255,857 | $261,000 | $218,738 | $252,204 |